Jonsson Comprehensive Cancer Center
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 56
- Registration Number
- NCT05688215
- Locations
- 🇺🇸
Yonemoto,Lisa, Los Angeles, California, United States
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 88
- Registration Number
- NCT05595499
- Locations
- 🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸UCLA Health Cancer Care in Alhambra, Alhambra, California, United States
🇺🇸UCLA Health Beverly Hills Primary & Specialty Care, Beverly Hills, California, United States
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
- First Posted Date
- 2022-09-28
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT05558904
- Locations
- 🇺🇸
Yesenia Calzada, Los Angeles, California, United States
Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT05523700
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 93
- Registration Number
- NCT05496959
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT05457959
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05398302
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
- Conditions
- Metastatic HER2-Positive Breast CarcinomaPrognostic Stage IB Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8
- Interventions
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT05319873
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT05256641
- Locations
- 🇺🇸
University of Oklahoma, Oklahoma City, Oklahoma, United States
🇺🇸UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
- Conditions
- Interventions
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05160597
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States